NHC Launches Online Value Classroom
The National Health Council (NHC) recently announced the launch of the Value Classroom, a new online learning platform aimed at [...]
HealthCore’s Beachler, Lanes Talk Bolstering RWE with New Tech
In the latest tHEORetically Speaking blog post, HealthCore's Daniel Beachler, Safety & Epidemiology associate director, and Stephen Lanes, Safety & [...]
ICER Names Venable VP of Patient Engagement
The Institute for Clinical and Economic Review (ICER) announced the appointment of Yvette Venable as its first-ever vice president of [...]
Health Care Industry Leveraging RWD to Combat COVID-19
The health care industry is looking to better leverage real-world data in the midst of the COVID-19 pandemic as it [...]
Program Looks to Address Gaps in COVID-19 Data
The Robert Wood Johnson Foundation's Health Data for Action program is supporting a collaboration between Health Care Cost Institute (HCCI), [...]
Clayton-Welch: Quality, Speed, Compliance Key in Dynamic Market Access Landscape
In the second of her five-part series on digital transformation in market access, HealthEconomics.Com© LLC CEO Patti Peeples sits down [...]
Prime Therapeutics Initiative Aims to Help Plan Sponsors Pay for Gene Therapies
The new PreserveRx program from Prime Therapeutics looks to help plan sponsors deal with high-cost gene therapies, Fierce Healthcare reports. [...]
The things you need to know about the digital transformation of primary research
In the rapidly evolving market access landscape, it’s important to quickly identify current payer perspectives to determine future trends. High-quality, rapid primary research can be key to fast-forwarding your strategy.
HealthEconomics.Com, Scientist.Com Announce HEOR, RWE Partnership
HealthEconomics.Com© LLC and Scientist.Com are partnering to streamline HEOR and real-world evidence sourcing in the global HEOR and RWE community [...]
Blog Post Highlights Impact Coronavirus Could Have on New Drug Launches
A recent blog post on Tribeca Knowledge outlines some of the key challenges pharmaceutical companies face regarding drug launches in [...]
Shkreli Seeks Furlough to Research Potential COVID-19 Treatments
Disgraced biotech entrepreneur Martin Shkreli is requesting a 3-month furlough to research potential treatments for COVID-19, STAT reports. In a [...]
ISPOR 2020 Goes Virtual
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is moving its annual meeting into the virtual space in response [...]
AMCP to Supreme Court: Ruling Against PCMA Could Raise Health Costs
The Academy of Managed Care Pharmacy (AMCP) in an amicus brief filed in the Supreme Court tells the court ruling [...]
MSK’s Bach Talks High-Value Drug Development
Memorial Sloan Kettering Cancer Center's Dr. Peter Bach in a recent interview with Liam Bendicksen discusses ways to optimize high-value [...]
ISPOR Task Force Publishes New Good Practices Reports
The International Society for Pharmacoeconomics and Outcomes Research's (ISPOR) Value of Information Analysis Emerging Good Practices Task Force has had [...]
Calculating Costs, Benefits of Lockdowns
How do economists calculate the value of preventing COVID-19 deaths? The authors of a recent article published on Forbes outline [...]
PRMA’s Chadwick Talks Digital Tech’s Impact on Market Access
PRMA Consulting HTA Manager Claire Chadwick outlines how digital technology is changing the face of the market access landscape in [...]
Article Outlines How Health Plans Utilize RWE for Specialty Drug Coverage
Health plans' use of real-world evidence for specialty drug coverage decisions is generally varied in terms of the number and [...]
Waystar: Poor Price Transparency is ‘Single Biggest Issue’ in Patient’s Financial Experience
In a sponsored article on HealthLeaders Media, Waystar outlines the patient's need for more "financial clarity" during their health care [...]
eyeforpharma Philadelphia Pivots to Virtual Event
In response to the COVID-19 outbreak, eyeforpharma is transitioning its eyeforpharma Philadelphia conference to a free, online event. The 4-day [...]
NICE Publishes COVID-19 Guidelines
The National Institute for Health and Care Excellence (NICE) on March 21 published a new set of guidelines that address [...]
Webinar – Faster to Market: Transforming HEOR & RWE Using Virtual Sourcing
Wish you could get HEOR & RWE projects started faster, cheaper, & using the most optimal vendor? Do you want [...]
Blog Post Mulls Indirect Benefits in Value Assessments
A recent blog post published on Health Affairs highlights some key reasons why indirect benefits should be factored into value [...]
Predictions for RWE in 2020
A recent article published on PharmaTimes looks at what the future may hold for real-world evidence amid rising interest in [...]
Lin: Clinical Practice Guidelines Not Broken
Family physician and Common Sense Family Doctor blogger Kenneth Lin in a recent post published on MedPage Today writes that [...]